Risk-adjusted return ratios before and after the COVID-19 pandemic
| Description | VT | CQQQ | FXI | GXC | MCHI |
|---|---|---|---|---|---|
| Calmar | |||||
| Before COVID-19 | 0.971 | 0.587 | 0.264 | 0.487 | 0.436 |
| After COVID-19 | 0.970 | 0.586 | 0.264 | 0.486 | 0.435 |
| Martin | |||||
| Before COVID-19 | 4.808 | 2.857 | 2.331 | 3.123 | 3.152 |
| After COVID-19 | 4.437 | 1.119 | −0.191 | 0.546 | 0.537 |
| Omega | |||||
| Before COVID-19 | 1.135 | 1.107 | 1.081 | 1.109 | 1.109 |
| After COVID-19 | 1.134 | 1.016 | 0.980 | 0.999 | 0.999 |
| Sharpe | |||||
| Before COVID-19 | 0.646 | 0.561 | 0.378 | 0.551 | 0.547 |
| After COVID-19 | 0.690 | 0.009 | −0.243 | −0.114 | −0.112 |
| Description | VT | CQQQ | FXI | GXC | MCHI |
|---|---|---|---|---|---|
| Calmar | |||||
| Before COVID-19 | 0.971 | 0.587 | 0.264 | 0.487 | 0.436 |
| After COVID-19 | 0.970 | 0.586 | 0.264 | 0.486 | 0.435 |
| Martin | |||||
| Before COVID-19 | 4.808 | 2.857 | 2.331 | 3.123 | 3.152 |
| After COVID-19 | 4.437 | 1.119 | −0.191 | 0.546 | 0.537 |
| Omega | |||||
| Before COVID-19 | 1.135 | 1.107 | 1.081 | 1.109 | 1.109 |
| After COVID-19 | 1.134 | 1.016 | 0.980 | 0.999 | 0.999 |
| Sharpe | |||||
| Before COVID-19 | 0.646 | 0.561 | 0.378 | 0.551 | 0.547 |
| After COVID-19 | 0.690 | 0.009 | −0.243 | −0.114 | −0.112 |
Note(s): This table compares the risk-adjusted return performance of four Chinese ETFs (CQQQ, FXI, GXC, MCHI) using Calmar, Martin, Omega, and Sharpe ratios across two periods: pre-COVID-19 (9/09/2014 to 1/02/2020) and post-COVID-19 (1/02/2020 to 6/09/2024). Based on all four measures, the Chinese ETFs were outperformed by VT in both periods. While CQQQ came closest to VT in several ratios before COVID-19, post-pandemic results showed a marked decline across all Chinese ETFs, especially in the Sharpe and Martin ratios, where some exhibited negative returns
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.